Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-Tympanic Magnevist MRI for Ménière's Disease
NCT02080312Completed
- Sponsor
- University of California, San Diego
- Start
- Jan 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of gadopentetate dimeglumine in Ménière's disease, sponsored by University of California, San Diego. Primary endpoints: Vestibular Endolymphatic Hydrops (EH) at 24 hours and Cochlear Endolymphatic Hydrops (EH) at 24 hours. Started Jan 2012; status: completed.
02
Drugs
gadopentetate dimeglumine
03
Conditions
Ménière's disease
Beyond the preview
Go deeper on NCT02080312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02080312.